Loading…
Oncolytics Biotech Inc. is projected to rise to $0.9195 by 2027, a +22% move from its current price of $0.7533. ONCY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.7277 | $0.7532 | $0.7795 | -0.01% |
| Aug 6 | $0.7173 | $0.7531 | $0.7906 | -0.03% |
| Aug 7 | $0.7094 | $0.753 | $0.7992 | -0.04% |
| Aug 8 | $0.7028 | $0.7529 | $0.8065 | -0.06% |
| Aug 9 | $0.697 | $0.7528 | $0.8129 | -0.07% |
| Aug 10 | $0.6918 | $0.7526 | $0.8188 | -0.09% |
| Aug 11 | $0.6871 | $0.7525 | $0.8242 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6871 | $0.7525 | $0.8242 | -0.10% |
| Week 2 | $0.661 | $0.7518 | $0.855 | -0.20% |
| Week 3 | $0.6415 | $0.751 | $0.8792 | -0.30% |
| Week 4 | $0.6254 | $0.7503 | $0.90 | -0.40% |
| Week 5 | $0.6115 | $0.7495 | $0.9186 | -0.51% |
| Week 6 | $0.5991 | $0.7487 | $0.9357 | -0.61% |
| Week 7 | $0.5879 | $0.748 | $0.9516 | -0.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company that engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of GI tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer.
It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Oncolytics Biotech Inc. (ONCY) trades at $0.7921 per share and has a market capitalization of $94.54M. It is ranked 4029 by market capitalization. The current price sits within a forecasted path that shows a neutral start in 2026, then a bullish trajectory with rising average prices and higher max targets into 2050.
The 2026 forecast shows an avg of $0.7921 with a min of $0.78 and a max of $0.9533, and a 0% ROI, indicating a neutral stance for that year.
A major floor 19.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.4% away) — a key level to hold.
The nearest ceiling, 27.4% above — a clean break opens room to run.
A major ceiling 52.7% above — clearing it would confirm fresh momentum.
Key ONCY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ONCY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.768 | Sell | $0.7689 | Sell |
| MA 10 | $0.804 | Sell | $0.7966 | Sell |
| MA 20 | $0.8425 | Sell | $0.8295 | Sell |
| MA 50 | $0.8732 | Sell | $0.8691 | Sell |
| MA 100 | $0.9122 | Sell | $0.9049 | Sell |
| MA 200 | $0.9706 | Sell | $0.9356 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.99 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -131.21 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -16.67 | Sell |
| Bollinger %B (20,2) | 0.08 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.36 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 18.48 | Buy |
| Momentum (10) | -0.10 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.73 | Buy |
| ADX (14) | 15.15 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is BEARISH. The RSI14 is 40. The SMA50 is $0.8784 and the SMA200 is $0.9799, highlighting near-term momentum below longer-term averages. The stock has support at $0.79 and resistance at $0.96, placing recent action within a narrow range near those levels.
The 30-day price range runs from a low of $0.6194 to a high of $1.01, and annualized volatility is 70%, underscoring elevated risk and variability over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.75 | $0.7533 | $0.9048 | 0% | Neutral | |
| $0.7162 | $0.9195 | $1.26 | +22% | Bullish | |
| $0.7644 | $1.02 | $1.46 | +35% | Bullish | |
| $0.7529 | $1.03 | $1.53 | +37% | Bullish | |
| $0.6998 | $0.9871 | $1.51 | +31% | Bullish | |
| $0.6988 | $1.01 | $1.58 | +34% | Bullish | |
| $0.757 | $1.12 | $1.80 | +49% | Bullish | |
| $0.8508 | $1.29 | $2.11 | +71% | Bullish | |
| $0.9709 | $1.50 | $2.50 | +99% | Bullish | |
| $0.9672 | $1.52 | $2.59 | +102% | Bullish | |
| $1.33 | $2.31 | $4.21 | +206% | Bullish | |
| $1.49 | $3.04 | $6.16 | +304% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.75 | $0.7533 | $0.8942 | +0.00% |
| September 2026 | $0.6072 | $0.7235 | $0.8901 | -3.96% |
| October 2026 | $0.6185 | $0.7434 | $0.927 | +2.76% |
| November 2026 | $0.6136 | $0.7428 | $0.9361 | -0.09% |
| December 2026 | $0.5835 | $0.711 | $0.9048 | -4.27% |
Click any year to see its month-by-month ONCY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ONCY is projected to trade between $0.75 and $0.9048, averaging $0.7533 — a potential gain of 0% from today's $0.7533. Price action looks broadly range-bound.
Oncolytics Biotech Inc.'s 2027 outlook centres on $0.9195, within a $0.7162 to $1.26 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ONCY could reach as high as $1.46, with a base case around $1.02 and support toward $0.7644 — roughly +35% from $0.7533. Momentum favours further upside here.
Expect ONCY to range from $0.7529 to $1.53 through 2029. The $1.03 average target implies a +37% move from current prices. That is up +2% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ONCY price prediction for 2030 points to an average of $0.9871 (low $0.6998, high $1.51) — a potential gain of +31% on today's $0.7533. Momentum favours further upside here.
In 2031, ONCY is projected to trade between $0.6988 and $1.58, averaging $1.01 — a potential gain of +34% from today's $0.7533. That is up +2% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Oncolytics Biotech Inc.'s 2032 outlook centres on $1.12, within a $0.757 to $1.80 range. That is up +11% on the projected 2031 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2033, ONCY could reach as high as $2.11, with a base case around $1.29 and support toward $0.8508 — roughly +71% from $0.7533. Buyers look set to stay in control over this stretch.
Expect ONCY to range from $0.9709 to $2.50 through 2034. The $1.50 average target implies a +99% move from current prices. That is up +17% on the projected 2033 average. Momentum favours further upside here.
The ONCY price prediction for 2035 points to an average of $1.52 (low $0.9672, high $2.59) — a potential gain of +102% on today's $0.7533. Buyers look set to stay in control over this stretch.
In 2040, ONCY is projected to trade between $1.33 and $4.21, averaging $2.31 — a potential gain of +206% from today's $0.7533. That is up +51% on the projected 2035 average. Momentum favours further upside here.
Oncolytics Biotech Inc.'s 2050 outlook centres on $3.04, within a $1.49 to $6.16 range. That is up +32% on the projected 2040 average. That marks a +304% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ONCY today (≈ 1,327.492367 ONCY) could be worth
$4,036.47
+$3,036.47 (+304%) by 2050 · US Dollar
Based on the average projected ONCY price of $3.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ONCYwould be worth at today's price.
$1,000 invested in ONCY on Jul 31, 2025 (≈ 980.392175 ONCY) would be worth
$738.53
-$261.47 (-26.1%) today · 0.74× · US Dollar
Based on a ONCY entry price of $1.02 vs. today's $0.7533.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.81 | $930 | -7.0% |
| 1 month ago | $0.9 | $837 | -16.3% |
| 3 months ago | $0.87 | $865.86 | -13.4% |
| 6 months ago | $0.97 | $776.6 | -22.3% |
| 1 year ago | $1.02 | $738.53 | -26.1% |
| All time (5.0y) ago | $2.19 | $343.97 | -65.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ONCY forecast.
Our base-case forecast reaches $1.50 around 2035.
Implied market cap at $1.50: $179.03M
The multi-year forecast paints a bullish rhythm after 2026, with rising averages and meaningful upside potential. From 2027 onward, the avg price increases from $0.9959 to higher levels, culminating in an avg of $3.27 by 2050 with an ROI of 313.4% and a bullish sentiment in the later years. Key milestone years include 2030 with an avg of $1.06 and ROI of 33.6%, 2040 with an avg of $2.54 and ROI of 220.8%, and 2050 with an avg of $3.27 and ROI of 313.4%.
The forecast also shows notable gains earlier in the period, such as 2032 avg $1.20 (ROI 51.7%) and 2033 avg $1.41 (ROI 77.9%), indicating a persistent uptrend through the decade. These are estimates and not guarantees, and actual results will depend on market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows min $0.7357, avg $1.06, max $1.65 with ROI 33.6% and sentiment BULLISH.
The forecast turns bullish from 2027 onward, with rising averages and positive ROI: 2027 avg $0.9959; 2028 avg $1.09; 2040 avg $2.54 with ROI 220.8%; 2050 avg $3.27 with ROI 313.4%.
Yes. The max values in the forecast exceed $2 in several years: 2033 max $2.37, 2034 max $2.78, 2035 max $2.89, 2040 max $4.78, and 2050 max $6.87.
The current price is $0.7921 and the annualized volatility is 70%.
The 30-day range is from a low of $0.6194 to a high of $1.01.
Oncolytics Biotech Inc. Community Discussion
0Share your Oncolytics Biotech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.